TP63 was identified as a differentially expressed gene (DEG) in cancer cell lines that acquired gefitinib resistance, and CSTA is one of the top 10 hub genes in a network of DEGs for gefitinib resistant cancer cell line [32]. Here, TP63 is linked to cancer.